The Best AI Stock to Own in the World Today is Trading for Just $25

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

John Gallina Biography and Net Worth

CFO of Elevance Health

John E. Gallina serves as Executive Vice President and Chief Financial Officer for Anthem, Inc., one of the nation’s leading health benefits companies serving over 41 million insured members within its family of health plans and representing approximately $117 billion in annual revenues. With more than 35 years of leadership experience, he oversees all finance and actuarial functions, inclusive of procurement and corporate real estate, and is also responsible for the company’s Healthcare Management organization, which encompasses all healthcare, clinical and network operations with a focus on the delivery of high quality and cost effective care. Previously, Gallina served as Senior Vice President and Chief Financial Officer of the Commercial and Specialty Business Division; Senior Vice President, Chief Accounting Officer and Chief Risk Officer; Senior Vice President, Internal Audit and Continuous Improvement; and Chief Financial Officer of Comprehensive Health Services. Before joining Anthem,he was an Audit Senior Manager at Coopers & Lybrand.

What is John E. Gallina's net worth?: The estimated net worth of John E. Gallina is at least $32.31 million as of May 24th, 2021. Mr. Gallina owns 60,095 shares of Elevance Health stock worth more than $32,308,875 as of April 26th. This net worth evaluation does not reflect any other assets that Mr. Gallina may own. Learn More about John E. Gallina's net worth.
How do I contact John E. Gallina?: The corporate mailing address for Mr. Gallina and other Elevance Health executives is 220 VIRGINIA AVENUE, INDIANAPOLIS IN, 46204. Elevance Health can also be reached via phone at (800) 331-1476 and via email at [email protected]. Learn More on John E. Gallina's contact information.
Has John E. Gallina been buying or selling shares of Elevance Health?: John E. Gallina has not been actively trading shares of Elevance Health during the last ninety days. Most recently, John E. Gallina sold 46,444 shares of the business's stock in a transaction on Monday, May 24th. The shares were sold at an average price of $394.89, for a transaction totalling $18,340,271.16. Following the completion of the sale, the chief financial officer now directly owns 60,095 shares of the company's stock, valued at $23,730,914.55. Learn More on John E. Gallina's trading history.
Who are Elevance Health's active insiders?: Elevance Health's insider roster includes Gail Boudreaux (CEO), Robert Dixon, Jr. (Director), John Gallina (CFO), Brian Griffin (CEO), Peter Haytaian (EVP), Julie Hill (Director), Charles Kendrick, Jr. (EVP), Gloria Mccarthy (EVP), Felicia Norwood (EVP), Ronald Penczek (CAO), Ramiro Peru (Director), Craig Samitt (EVP), Ryan Schneider (Director), Joseph Swedish (Insider), Jose Tomas (EVP), and Thomas Zielinski (EVP). Learn More on Elevance Health's active insiders.
Are insiders buying or selling shares of Elevance Health?: In the last year, insiders at the sold shares 4 times. They sold a total of 15,238 shares worth more than $8,084,963.64. The most recent insider tranaction occured on April, 23rd when EVP Felicia F Norwood sold 14,111 shares worth more than $7,531,605.14. Insiders at Elevance Health own 0.4% of the company. Learn More about insider trades at Elevance Health.
Information on this page was last updated on 4/23/2024.

John E. Gallina Insider Trading History at Elevance Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/24/2021	Sell	46,444	$394.89	$18,340,271.16	60,095
3/5/2018	Sell	24,576	$229.81	$5,647,810.56	22,139
3/3/2015	Sell	39,556	$145.30	$5,747,486.80

John E. Gallina Buying and Selling Activity at Elevance Health

Elevance Health Company Overview

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Today's Range

Now: $537.63

$529.98

$539.12

50 Day Range

MA: $511.40

$497.60

$539.70

2 Week Range

Now: $537.63

$412.00

$542.07

Volume

253,418 shs

Average Volume

1,054,273 shs

Market Capitalization

$124.96 billion

P/E Ratio

20.32

Dividend Yield

1.22%

Beta

0.78

The Best AI Stock to Own in the World Today is Trading for Just $25

From Banyan Hill Publishing | Ad

See how you can invest alongside him